Related references
Note: Only part of the references are listed.Methods for the Determination of Transition Metal Impurities in Cyclotron-Produced Radiometals
Viktoria Forgacs et al.
PHARMACEUTICALS (2022)
A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor-Positive Prostate Cancer
Ivica J. Bratanovic et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Synthesis, Physicochemical, Labeling and In Vivo Characterization of 44Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe
Daniel Szucs et al.
PHARMACEUTICALS (2022)
Preclinical Evaluation of Novel 64Cu-Labeled Gastrin-Releasing Peptide Receptor Bioconjugates for PET Imaging of Prostate Cancer
George Makris et al.
BIOCONJUGATE CHEMISTRY (2021)
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?
Pinuccia Faviana et al.
FRONTIERS IN ONCOLOGY (2021)
A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models
Jules Zhang-Yin et al.
NUCLEAR MEDICINE AND BIOLOGY (2020)
In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68Ga-labelled NGR derivatives using PET/MRI imaging
Adrienn Kis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific 68Ga-and 44Sc-labeled DOTA-NAPamide in melanoma imaging
Gabor Nagy et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer 68Ga-NODAGA-Procainamide
Istvan Kertesz et al.
JOURNAL OF CANCER (2017)
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
Christoph A. Umbricht et al.
EJNMMI RESEARCH (2017)
AAZTA: An Ideal Chelating Agent for the Development of 44Sc PET Imaging Agents
Gabor Nagy et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57
Johan Hygum Dam et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Imaging quality of 44Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET
Maruta Bunka et al.
APPLIED RADIATION AND ISOTOPES (2016)
Co-administration of succinylated gelatine with a 99mTc-bombesin analogue, effects on pharmacokinetics and tumor uptake
Christos C. Liolios et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations
Katharina A. Domnanich et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2016)
Evaluation of a 64Cu-labeled 1,4,7-triazacyclononane, 1-glutaric acid-4,7 acetic acid (NODAGA)-galactose-bombesin analogue as a PET imaging probe in a gastrin-releasing peptide receptor-expressing prostate cancer xenograft model
Min Hwan Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with 44Sc-Labeled Cetuximab Fab Fragment
Rubel Chakravarty et al.
BIOCONJUGATE CHEMISTRY (2014)
Influence of different chelators on the radiochemical properties of a 68-Gallium labelled bombesin analogue
Mattia Asti et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Functional and molecular imaging of localized and recurrent prostate cancer
Kinzya Grant et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
A Comparative Study of Radio labeled Bombesin Analogs for the PET Imaging of Prostate Cancer
Yang Liu et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Promises of Cyclotron-Produced 44Sc as a Diagnostic Match for Trivalent β--Emitters: In Vitro and In Vivo Study of a 44Sc-DOTA-Folate Conjugate
Cristina Mueller et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Novel Radiolabeled Peptides for Breast and Prostate Tumor PET Imaging: 64Cu/and 68Ga/NOTA-PEG-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14)
Patrick Fournier et al.
BIOCONJUGATE CHEMISTRY (2012)
Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
Johannes Notni et al.
EJNMMI RESEARCH (2012)
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts
Rogier P. J. Schroeder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Radiopeptide Imaging and Therapy in the United States
Michael M. Graham et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
PET of Somatostatin Receptor-Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference
Melpomeni Fani et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
Rogier P. J. Schroeder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
Carolyn J. Anderson et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides
Rosalba Mansi et al.
CLINICAL CANCER RESEARCH (2009)
Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues
R. P. J. Schroeder et al.
METHODS (2009)
Regulation and signaling of human bombesin receptors and their biological effects
H. Christian Weber
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Ga-68-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals
Melpomeni Fani et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2008)
Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide-Receptor Targeted Radiopharmaceuticals
H. J. K. Ananias et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC
Mattia Asti et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
R. T. Jensen et al.
PHARMACOLOGICAL REVIEWS (2008)
The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter
DM Xiao et al.
GENE (2001)
Share Paper
